Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery
Year: 2017
Type: article
Abstract: In a Perspective, David Bennett makes a case for neural reserve to be considered as a therapeutic endpoint in clinical trials for dementia.
Source: PLoS Medicine
Author: David A. Bennett
Institution: Rush University Medical Center
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $6,460
Awards: Epidemiologic Study of Neural Reserve and Neurobiology of Aging, Pathway discovery, validation and compound identification for Alzheimer's disease, Risk Factors, Pathology, and Clinical Expressions of AD, Rush Alzheimer's Disease Core Center, Risk Factors, Pathology, and Clinical Expressions of AD
OpenAlex ID: W2599229533
